Július Gelžinský

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 350 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Coronary Artery Disease +9

The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?

Otto Mayer, Július Gelžinský, Jitka Seidlerová et al. · Journal of Human Hypertension · 2020 · 23 citations

Aging, Anti-aging, Cardiovascular Disease +9

Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population?

Július Gelžinský, Otto Mayer, Jitka Seidlerová et al. · Hypertension Research · 2021 · 22 citations

Vascular Disease, Cardiovascular Disease, Skin Autofluorescence +11

In the aftermath of SPRINT: further comparison of unattended automated office blood pressure measurement and 24-hour blood pressure monitoring

Jitka Seidlerová, Július Gelžinský, Markéta Mateřánková et al. · Blood Pressure · 2018 · 17 citations · Full text

Mood disorders impaired quality of life but not the mortality or morbidity risk in stable coronary heart disease patients

Otto Mayer, Jan Bruthans, Jitka Seidlerová et al. · Acta cardiologica. Supplementum · 2019 · 16 citations